Authors

Latest:

PrimeMD, a Pain Reporting Smartphone Application for Patients Undergoing Head and Neck Radiation

A feasibility study of a smartphone application that patients undergoing radiation therapy for head and neck cancer can use to regularly report mucositis symptoms.

Shell Portner, RN, BSN

Latest:

Treatment Ends, but the Need for Care Continues

Celebration at the end of cancer treatment is often premature.

Shella Saint Fleur-Lominy, MD, PhD

Latest:

Dr Fleur-Lominy on Ongoing Research Within CML at the 2024 ASCO Annual Meeting

Shella Saint Fleur-Lominy, MD, PhD, and Yan Leyfman, MD, discuss ongoing research within the chronic myeloid leukemia patient population.

Shereen Stutz, RPH

Latest:

The FDA Could Help Address Financial Toxicity During the Approval Process

Given the widespread financial impact the high cost of cancer drugs has on the healthcare system, it may be time for the FDA to take a broader approach when reviewing oncology drug applications. By also examining the cost of the drug, the FDA could shine a light on escalating drug costs and play a leadership role in creating new programs and initiatives that help patients pay for promising new therapies.

Sherene Loi, MD, PhD

Latest:

Dr. Loi on the Association Between TILs and Trastuzumab

Sherene Loi, MD, PhD, on the association between immune cells and a pathologic complete response in patients with breast cancer after being given chemotherapy and trastuzumab.

Sheri Holmen, PhD

Latest:

Sheri Holmen on Understanding Drivers of Melanoma Metastasis

Sheri Holmen, PhD, investigator, Associate Professor in the Department of Surgery, Adjunct Professor in the Department of Oncological Sciences, Huntsman Cancer Institute, the University of Utah School of Medicine, discusses understanding drivers for melanoma metastasis.

Sherif S. Farag, MD, Indiana University Health

Sherrif F. Ibrahim, MD, PhD

Latest:

Update on Vismodegib's Place in the Treatment of Advanced BCC

Basal cell carcinoma (BCC) is the most common human malignancy and by far the most prevalent form of skin cancer, accounting for more than 80% of all cases.

Shikha Jain, MD

Latest:

Dr. Jain on the Push Toward Personalized Treatment Approaches in CRC With Liver Metastases

Shikha Jain, MD, FACP, discusses the push toward personalized treatment approaches in colorectal cancer with liver metastases.

Shilpa Gupta, MD, Cleveland Clinic

Latest:

Dr Gupta on Avelumab Maintenance in Urothelial Carcinoma With/Without Diabetes Mellitus

Shilpa Gupta, MD, discusses data from a subgroup analysis of the phase 3 JAVELIN Bladder 100 and future questions surrounding the use of avelumab maintenance in this setting.

Shin Yin Lee, MD

Latest:

Geriatric Oncology: Learning the Balancing Act of Treating the Older Cancer Patient

Whether it be to identify a seemingly frail older patient with metastatic colon cancer who would tolerate and benefit from standard treatment, or to prevent a frail older lung cancer patient from experiencing severe side effects due to adjuvant chemotherapy, oncologists are having to make difficult decisions with increasing frequency.

Shirish Gadgeel, MD

Latest:

Leveraging ctDNA Platforms in High-Risk Patients: Current Applications and Future Potential

Panelists discuss how they currently utilize emerging ctDNA platforms for high-risk patients and explore whether these advancements will soon become standard practice in clinical decision-making.

Shirish Gadgeel, MD, Wayne State University School of Medicine

Shirish M. Gadgeel, MD, MBBS

Latest:

Dr. Gadgeel on the Utility of Liquid Biopsies in Lung Cancer

Shirish M. Gadgeel, MD, MBBS, Mary Lou Kennedy Research Professor in Thoracic Oncology, professor, Department of Internal Medicine, Division of Hematology/Oncology, co-leader, Thoracic Oncology Research Program, and associate director, Networking and Affiliated Centers, University of Michigan Medicine, discusses the utility of liquid biopsies in lung cancer.

Shirish M. Gadgeel, MD, MBBS Rogel Cancer Center

Shirish M. Gadgeel, MD, University of Michigan

Shirley Michelle Shiller, DO

Latest:

Evolution in the Field of HR+ Breast Cancer Management

Closing out their discussion on HR+ breast cancer management, expert panelists share their excitement for the evolving treatment paradigm.

Shivani Parmar, MPH

Latest:

5 Questions... with Cliff Chirls, President and COO of iMedExchange

Clifford Chirls discusses the features of the new social networking site iMedExchange and explains how it diff ers from other social networking resources for physicians.

Shiven B. Patel, MD, MBA, FACP

Latest:

Dr. Patel on Treatment Considerations in Advanced Squamous NSCLC

Shiven B. Patel, MD, MBA, FACP, discusses treatment considerations in patients with advanced squamous non–small cell lung cancer.

Shlomo Koyfman, MD

Latest:

Dr. Koyfman on Reirradiation Options for Head and Neck Cancer

Shlomo Koyfman, MD, associate staff, radiation oncology, Cleveland Clinic, discusses reirradiation options for patients with head and neck cancer.